Skip to main content
. 2016 Jul 6;104(2):324–333. doi: 10.3945/ajcn.116.133561

TABLE 4.

Overnight fasted plasma concentrations measured during the BD and KD periods1

BD (n = 17) KD (n = 17) P2
Acetoacetate, mmol/L 0.108 ± 0.075 0.781 ± 0.069 <0.0001
BHB, mmol/L 0.103 ± 0.071 0.758 ± 0.066 <0.0001
FFAs, mmol/L 0.479 ± 0.035 0.803 ± 0.029 <0.0001
Glycerol, mg/L 7.21 ± 0.78 11.1 ± 0.66 0.0006
Glucose, mg/dL 81.4 ± 1.5 81.9 ± 1.4 0.664
Glucagon, pg/mL 93.6 ± 8.9 126 ± 8.6 <0.0001
C-peptide,3 ng/mL 1.47 ± 0.11 1.15 ± 0.11 <0.0001
Insulin,3 μU/mL 7.92 ± 0.93 6.27 ± 0.9 0.0039
Triglyceride, mg/dL 104 ± 6.4 85.4 ± 6 0.001
Leptin, ng/mL 8.94 ± 1.1 7.13 ± 1.1 <0.0001
TSH, μIU/mL 1.84 ± 0.19 1.98 ± 0.18 0.0448
Free thyroxine, ng/dL 1.18 ± 0.033 1.32 ± 0.032 <0.0001
Total thyroxine, μg/dL 6.56 ± 0.3 6.76 ± 0.3 0.109
Free tri-iodothyronine, pg/mL 2.85 ± 0.097 2.5 ± 0.094 <0.0001
Total tri-iodothyronine, ng/dL 95.1 ± 3.6 75.7 ± 3.4 <0.0001
1

All values are least squares means ± SEs. The data were analyzed by using a repeated-measures mixed model. BD, high-carbohydrate baseline diet; BHB, β-hydroxybutyrate; FFA, free fatty acid; KD, low-carbohydrate ketogenic diet; TSH, thyroid-stimulating hormone.

2

Values refer to the effects of the diet period and were not corrected for multiple comparisons.

3

n = 16 for the only final time point during the KD as a result of a single outlier described in the main text.